Recombinant interferon α-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: A 3-year trial with recombinant interferon-α and 5-year follow-up

Luigi Rusciani, Ilaria Proietti, Andrea Paradisi, Antonio Rusciani, Giuseppe Guerriero, Alessia Mammone, Andrea De Gaetano, Silvio Lippa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Recombinant interferon α-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: A 3-year trial with recombinant interferon-α and 5-year follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences